-
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Chemical research in toxicology 20150518
-
Resveratrol and clofarabine induces a preferential apoptosis-activating effect on malignant mesothelioma cells by Mcl-1 down-regulation and caspase-3 activation.
BMB reports 20150301
-
Knockdown of Bcl-xL enhances growth-inhibiting and apoptosis-inducing effects of resveratrol and clofarabine in malignant mesothelioma H-2452 cells.
Journal of Korean medical science 20141101
-
Resveratrol contributes to chemosensitivity of malignant mesothelioma cells with activation of p53.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20140101
-
Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20130201
-
Efficacy of RNA polymerase II inhibitors in targeting dormant leukaemia cells.
BMC pharmacology & toxicology 20130101
-
Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells.
Pediatric blood & cancer 20121215
-
Phase I dose-escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias.
Pediatric blood & cancer 20121215
-
Synergism between clofarabine and decitabine through p53R2: a pharmacodynamic drug-drug interaction modeling.
Leukemia research 20121101
-
Nucleoside analogue electrochemical behaviour and in situ evaluation of DNA-clofarabine interaction.
Bioelectrochemistry (Amsterdam, Netherlands) 20121001
-
Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients.
Cancer 20120915
-
Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients.
Leukemia & lymphoma 20120901
-
Clofarabine in pediatric acute leukemia: current findings and issues.
Pediatric blood & cancer 20120901
-
Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT.
European journal of haematology 20120901
-
Tangled up in knots: structures of inactivated forms of E. coli class Ia ribonucleotide reductase.
Structure (London, England : 1993) 20120808
-
Clofarabine and CY do not yield reliable engraftment of hematopoietic stem cells.
Bone marrow transplantation 20120801
-
Clofarabine targets the large subunit (α) of human ribonucleotide reductase in live cells by assembly into persistent hexamers.
Chemistry & biology 20120727
-
Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710
-
A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia.
Leukemia & lymphoma 20120701
-
Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.
Biochemical pharmacology 20120701
-
Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AML.
Leukemia research 20120701
-
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias.
British journal of haematology 20120701
-
Drug shortages delay cancer clinical trials.
Journal of the National Cancer Institute 20120620
-
Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601
-
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120601
-
Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.
American journal of hematology 20120601
-
[Effect of clofarabine on proliferation and Bcl-2 expression of NB4 cells].
Zhongguo shi yan xue ye xue za zhi 20120601
-
Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors.
Naunyn-Schmiedeberg's archives of pharmacology 20120501
-
ABC transporters and their role in nucleoside and nucleotide drug resistance.
Biochemical pharmacology 20120415
-
Acute leukemia in adults: novel allogeneic transplant strategies.
Hematology (Amsterdam, Netherlands) 20120401
-
A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120301
-
Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia.
Leukemia & lymphoma 20120301
-
Synergistic antitumor interactions between gemcitabine and clofarabine in human pancreatic cancer cell lines.
Molecular medicine reports 20120301
-
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.
Cancer 20120201
-
DNA building blocks: keeping control of manufacture.
Critical reviews in biochemistry and molecular biology 20120201
-
Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120201
-
Treatment of acute lymphoblastic leukemia in adults.
Critical reviews in oncology/hematology 20120101
-
Institutional experience with clofarabine and cytarabine in relapsed pediatric acute myeloid leukemia.
Journal of pediatric hematology/oncology 20120101
-
Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.
British journal of haematology 20120101
-
Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome.
European journal of haematology 20120101
-
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107).
British journal of haematology 20120101
-
Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
The Annals of pharmacotherapy 20120101
-
Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia.
Clinical Medicine Insights. Oncology 20120101
-
Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.
TheScientificWorldJournal 20120101
-
Novel therapies for aggressive B-cell lymphoma.
Advances in hematology 20120101
-
Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.
Current pharmaceutical design 20120101
-
Immunotherapy targets in pediatric cancer.
Frontiers in oncology 20120101
-
Acute myeloid leukemia: focus on novel therapeutic strategies.
Clinical Medicine Insights. Oncology 20120101
-
Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism.
PloS one 20120101
-
Preclinical antitumor activity of thiarabine in human leukemia and lymphoma xenograft models.
Nucleosides, nucleotides & nucleic acids 20120101
-
Preclinical combination therapy of clofarabine plus radiation.
Nucleosides, nucleotides & nucleic acids 20120101
-
Treatment of elderly acute myeloid leukemia patients.
Current treatment options in oncology 20111201
-
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Blood 20111201
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia.
Annals of hematology 20111101
-
Isolation and characterization of a murine P388 leukemia line resistant to clofarabine.
Nucleosides, nucleotides & nucleic acids 20111101
-
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.
Blood 20111013
-
Clofarabine as a potential stimulant of alloreactivity.
Bone marrow transplantation 20111001
-
Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia.
British journal of haematology 20111001
-
Failure of hypomethylating agent-based therapy in myelodysplastic syndromes.
Seminars in oncology 20111001
-
Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+cytarabine.
Leukemia research 20110901
-
Applicability of a 'Pick a Winner' trial design to acute myeloid leukemia.
Blood 20110901
-
Determination of clofarabine triphosphate concentrations in leukemia cells using sensitive, isocratic high-performance liquid chromatography.
Anticancer research 20110901
-
Clofarabine-associated acute kidney injury and proteinuria.
Pharmacotherapy 20110901
-
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820
-
Acute myeloid leukaemia: optimal management and recent developments.
Drugs 20110820
-
Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines.
Journal of medicinal chemistry 20110811
-
Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
British journal of haematology 20110801
-
[Novel conventional therapies in onco-hemathology].
Bulletin du cancer 20110801
-
Improving the outcomes of elderly patients with acute myeloid leukemia in a Brazilian University Hospital.
Clinics (Sao Paulo, Brazil) 20110801
-
A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory non-Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701
-
Clofarabine for myelodysplastic syndromes.
Expert opinion on investigational drugs 20110701
-
Busulfan and metronidazole: an often forgotten but significant drug interaction.
The Annals of pharmacotherapy 20110701
-
Acute lymphoblastic leukemia in adults.
Pediatric reports 20110622
-
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601
-
Pharmacokinetics of clofarabine in patients with high-risk inherited metabolic disorders undergoing brain-sparing hematopoietic cell transplantation.
Journal of clinical pharmacology 20110501
-
Educational paper. The development of new therapies for pediatric oncology.
European journal of pediatrics 20110501
-
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
Cancer chemotherapy and pharmacology 20110401
-
Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway.
European journal of nuclear medicine and molecular imaging 20110401
-
Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia.
Leukemia 20110401
-
Efficacy and safety of clofarabine in relapsed and/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients.
Cancer 20110401
-
Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.
Cancer research 20110301
-
New nucleoside analogs for patients with hematological malignancies.
Expert opinion on investigational drugs 20110301
-
Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure.
American journal of hematology 20110301
-
Novel agents for the treatment of acute myeloid leukemia in the older patient.
Journal of the National Comprehensive Cancer Network : JNCCN 20110301
-
New drug therapies in peripheral T-cell lymphoma.
Expert review of anticancer therapy 20110301
-
A network meta-analysis of randomized controlled trials of induction treatments in acute myeloid leukemia in the elderly.
Clinical therapeutics 20110301
-
Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity.
The oncologist 20110201
-
Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine.
Clinical journal of oncology nursing 20110201
-
Treatment of unfit patients with acute myeloid leukemia: a still open clinical challenge.
Clinical lymphoma, myeloma & leukemia 20110201
-
The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling.
Biochemical pharmacology 20110115
-
Clofarabine for treatment of acute lymphoblastic leukaemia in adults.
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101
-
Novel and emerging drugs for acute myeloid leukemia: pharmacology and therapeutic activity.
Current medicinal chemistry 20110101
-
Interpreting clinical assays for histone deacetylase inhibitors.
Cancer management and research 20110101
-
Clofarabine (2-chloro-2'-fluoro-2'-deoxyarabinosyladenine)--biochemical aspects of anticancer activity.
Acta poloniae pharmaceutica 20110101
-
A rapidly progressing Pancoast syndrome due to pulmonary mucormycosis: a case report.
Journal of medical case reports 20110101
-
Fermented wheat germ extract--nutritional supplement or anticancer drug?
Nutrition journal 20110101
-
Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia.
OncoTargets and therapy 20110101
-
Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment.
Marine drugs 20110101
-
An update on the management of peripheral T-cell lymphoma and emerging treatment options.
Journal of blood medicine 20110101
-
Phenotypic enhancement of thymidylate synthetase pathway inhibitors following ablation of Neil1 DNA glycosylase/lyase.
Cell cycle (Georgetown, Tex.) 20101215
-
Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML.
Bone marrow transplantation 20101201
-
A phase II study of low dose intravenous clofarabine for elderly patients with myelodysplastic syndrome who have failed 5-azacytidine.
Leukemia & lymphoma 20101201
-
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.
British journal of haematology 20101201
-
Influence of clofarabine on transcriptional activity of PTEN, APC, RARB2, ZAP70 genes in K562 cells.
Anticancer research 20101101
-
Rare tumors research in emerging countries.
Rare tumors 20100930
-
Clofarabine in the treatment of poor risk acute myeloid leukaemia.
Hematological oncology 20100901
-
Ulcerated plaque under a ruby ring in an immunosuppressed patient.
Dermatology online journal 20100815
-
Current and future management options for myelodysplastic syndromes.
Drugs 20100730
-
Effect of hemodialysis on the plasma levels of clofarabine.
Pediatric blood & cancer 20100715
-
Novel PET probes specific for deoxycytidine kinase.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100701
-
Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.
Environmental and molecular mutagenesis 20100701
-
New trends in nucleoside biotechnology.
Acta naturae 20100701
-
Renal excretion of clofarabine: assessment of dose-linearity and role of renal transport systems on drug excretion.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100614
-
Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100601
-
Development of therapeutic agents for older patients with acute myelogenous leukemia.
Current opinion in investigational drugs (London, England : 2000) 20100601
-
Effect of clofarabine on apoptosis and DNA synthesis in human epithelial colon cancer cells.
Nucleosides, nucleotides & nucleic acids 20100601
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20100601
-
Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission.
The Korean journal of hematology 20100601
-
European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510
-
Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.
Pediatric blood & cancer 20100501
-
Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapy.
Clinical advances in hematology & oncology : H&O 20100501
-
Fatal neurotoxicity in a patient with down syndrome treated with chemotherapy, irradiation, stem cell transplant, and clofarabine.
Journal of pediatric hematology/oncology 20100401
-
Novel therapies for myelodysplastic syndromes.
Hematology/oncology clinics of North America 20100401
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20100401
-
Clofarabine-induced capillary leak syndrome in a child with refractory acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology 20100301
-
Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100201
-
Efficient syntheses of clofarabine and gemcitabine from 2-deoxyribonolactone.
Nucleosides, nucleotides & nucleic acids 20100201
-
Clofarabine in leukemia.
Expert review of hematology 20100201
-
6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents.
Journal of medicinal chemistry 20100114
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20100101
-
Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights.
Journal of hematology & oncology 20100101
-
Challenges in treating older patients with acute myeloid leukemia.
Journal of oncology 20100101
-
Use of clofarabine for acute childhood leukemia.
Biologics : targets & therapy 20100101
-
Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia.
Molecular cancer 20100101
-
Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine.
OncoTargets and therapy 20100101
-
Clofarabine-based regimen as useful bridge therapy for allogeneic transplantation in myeloid blast crisis of Philadelphia-positive chronic myeloid leukemia resistant to imatinib and dasatinib.
Acta haematologica 20100101
-
Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.
Molecular cancer 20100101
-
An update in management of noncutaneous T-cell lymphomas.
Advances in hematology 20100101
-
Application of new drugs in chronic lymphocytic leukemia.
Mediterranean journal of hematology and infectious diseases 20100101
-
New treatments for myelodysplastic syndromes.
Mediterranean journal of hematology and infectious diseases 20100101
-
Clofarabine induces hypomethylation of DNA and expression of Cancer-Testis antigens.
Leukemia research 20091201
-
Mechanisms of anti-cancer action and pharmacology of clofarabine.
Biochemical pharmacology 20091201
-
Acute myeloid leukemia and ischemic heart disease successful first line treatment with clofarabine as single agent.
Leukemia research 20091201
-
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.
Leukemia 20091201
-
Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia.
American journal of hematology 20091201
-
Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case series.
Leukemia & lymphoma 20091201
-
Impaired S-phase arrest in acute myeloid leukemia cells with a FLT3 internal tandem duplication treated with clofarabine.
Clinical cancer research : an official journal of the American Association for Cancer Research 20091201
-
Last exit clofarabine?
Leukemia & lymphoma 20091201
-
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia.
British journal of haematology 20091101
-
New insights in the management of elderly patients with acute myeloid leukemia.
Current opinion in oncology 20091101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20091101
-
Advanced Philadelphia chromosome positive acute lymphoblastic leukemia patients relapsed after treatment with tyrosine-kinase inhibitors: successful response to clofarabine and cyclophosphamide.
Haematologica 20091001
-
Clofarabine: emerging role in leukemias.
Expert opinion on investigational drugs 20091001
-
Recent progress in the treatment of acute lymphoblastic leukemia: clofarabine.
Hematology/oncology clinics of North America 20091001
-
Genetic factors influencing cytarabine therapy.
Pharmacogenomics 20091001
-
Clofarabine for the treatment of adult acute myeloid leukemia.
Future oncology (London, England) 20091001
-
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090910
-
Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
Cancer chemotherapy and pharmacology 20090701
-
Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.
Bone marrow transplantation 20090701
-
Diffusion-driven device for a high-resolution dose-response profiling of combination chemotherapy.
Analytical chemistry 20090701
-
Clofarabine in relapsed lymphoma: what is the optimal dose?
Leukemia & lymphoma 20090701
-
Novel therapies for relapsed acute lymphoblastic leukemia.
Current hematologic malignancy reports 20090701
-
Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.
British journal of cancer 20090616
-
Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.
American journal of physiology. Renal physiology 20090601
-
Clofarabine: a new treatment option for patients with acute myeloid leukemia.
Expert opinion on pharmacotherapy 20090601
-
Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
Mini reviews in medicinal chemistry 20090601
-
Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
International journal of oncology 20090501
-
Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.
Anticancer research 20090501
-
Safety of conditioning agents for allogeneic haematopoietic transplantation.
Expert opinion on drug safety 20090501
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20090501
-
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
American journal of hematology 20090401
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20090401
-
Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.
Molecules (Basel, Switzerland) 20090323
-
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.
Leukemia & lymphoma 20090301
-
Clofarabine: a size that fits all, may not fit all.
Leukemia & lymphoma 20090301
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20090301
-
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.
Cancer 20090101
-
ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
BMC cancer 20090101
-
Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin.
Clinical interventions in aging 20090101
-
Drugs associated with more suicidal ideations are also associated with more suicide attempts.
PloS one 20090101
-
Managing myelodysplastic symptoms in elderly patients.
Clinical interventions in aging 20090101
-
Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia.
Drug design, development and therapy 20090101
-
Clofarabine in refractory Langerhans cell histiocytosis.
Pediatric blood & cancer 20081101
-
Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.
Clinical advances in hematology & oncology : H&O 20081101
-
New agents for the treatment of AML recent study findings.
Clinical advances in hematology & oncology : H&O 20081101
-
Clofarabine combinations as acute myeloid leukemia salvage therapy.
Cancer 20081015
-
Clofarabine: in search of combinations for the treatment of patients with high-risk acute myeloid leukemia.
Cancer 20081015
-
Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues.
Leukemia research 20081001
-
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.
Blood 20080901
-
Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides.
Molecular cancer therapeutics 20080901
-
Acute myeloid leukemia in the elderly.
Seminars in oncology 20080801
-
New drugs in acute myeloid leukemia.
Seminars in oncology 20080801
-
Synthetic studies on formamidopyrimidines related to clofarabine.
Nucleosides, nucleotides & nucleic acids 20080801
-
Acute myeloid leukemia in the elderly: conventional and novel treatment approaches.
Blood reviews 20080701
-
Novel purine nucleoside analogues for hematological malignancies.
Recent patents on anti-cancer drug discovery 20080601
-
Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.
Biochemical pharmacology 20080515
-
Fatal skin and liver toxicity in a patient treated with clofarabine.
Pediatric blood & cancer 20080501
-
Treating refractory leukemias in childhood, role of clofarabine.
Therapeutics and clinical risk management 20080401
-
Potential role of novel nucleoside analogs in the treatment of acute myeloid leukemia.
Current opinion in hematology 20080301
-
Clofarabine acts as radiosensitizer in vitro and in vivo by interfering with DNA damage response.
International journal of radiation oncology, biology, physics 20080101
-
The combination of clofarabine and cytarabine in pediatric relapsed acute lymphoblastic leukemia: a case report.
Chemotherapy 20080101
-
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
Current medicinal chemistry 20080101
-
Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants.
The Journal of pharmacology and experimental therapeutics 20071201
-
Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
Seminars in oncology 20071201
-
Clofarabine: new drug. Children with acute lymphoblastic leukaemia: a last resort.
Prescrire international 20071201
-
Clofarabine: past, present, and future.
Leukemia & lymphoma 20071001
-
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.
Blood 20070915
-
Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia.
Journal of pediatric hematology/oncology 20070901
-
Saccharomyces cerevisiae emboli in an immunocompromised patient with relapsed acute myeloid leukaemia.
Clinical and experimental dermatology 20070701
-
Comparison of fast liquid chromatography/tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma.
Journal of pharmaceutical and biomedical analysis 20070628
-
Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes.
Biochemical and biophysical research communications 20070615
-
In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia.
British journal of haematology 20070401
-
Advances in the management of AML in the elderly.
Clinical advances in hematology & oncology : H&O 20070301
-
Clofarabine for the treatment of acute lymphoblastic leukemia.
Expert review of anticancer therapy 20070201
-
Nursing considerations for clofarabine in the treatment of acute lymphoblastic leukemia in children.
Clinical journal of oncology nursing 20061201
-
Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia.
The Yale journal of biology and medicine 20061201
-
Clofarabine and nelarabine: two new purine nucleoside analogs.
Current opinion in oncology 20061101
-
The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma.
Haematologica 20061101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20061101
-
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
Nature reviews. Drug discovery 20061001
-
A tale of two drugs.
Nature reviews. Drug discovery 20061001
-
New directions in the treatment of mantle cell lymphoma: an overview.
Clinical lymphoma & myeloma 20061001
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20061001
-
Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older.
Blood 20060701
-
Clinical and pharmacokinetic study of clofarabine in chronic lymphocytic leukemia: strategy for treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 20060701
-
Pharmacological and clinical studies on purine nucleoside analogs--new anticancer agents.
Mini reviews in medicinal chemistry 20060501
-
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420
-
Treatment of older patients with acute myeloid leukemia--new agents.
Seminars in hematology 20060401
-
The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
Acta crystallographica. Section D, Biological crystallography 20060201
-
New drugs 06, part I.
Nursing 20060201
-
A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
Molecular pharmacology 20060101
-
New agents for the treatment of acute myeloid leukemia.
Best practice & research. Clinical haematology 20060101
-
Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Current medicinal chemistry 20060101
-
Pediatric drug trials facing some obstacles.
Journal of the National Cancer Institute 20051207
-
Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
Expert opinion on pharmacotherapy 20051201
-
New agents in the treatment of childhood leukemias and myelodysplastic syndromes.
Current oncology reports 20051101
-
Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.
Current cancer drug targets 20050901
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20050901
-
Plasma and cerebrospinal fluid pharmacokinetics of clofarabine in nonhuman primates.
Clinical cancer research : an official journal of the American Association for Cancer Research 20050815
-
The distribution, metabolism, and elimination of clofarabine in rats.
Drug metabolism and disposition: the biological fate of chemicals 20050601
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20050601
-
The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
Cancer 20050515
-
Clofarabine.
Nature reviews. Drug discovery 20050501
-
Clofarabine.
Nature reviews. Drug discovery 20050501
-
Biochemical modulation of cytarabine triphosphate by clofarabine.
Cancer chemotherapy and pharmacology 20050401
-
Complete remission following clofarabine treatment in refractory juvenile myelomonocytic leukemia.
Journal of pediatric hematology/oncology 20050301
-
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.
Blood 20050201
-
New drugs and dosage forms.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050201
-
Clofarabine: in pediatric patients with acute lymphoblastic leukemia.
Paediatric drugs 20050101
-
New drugs: tigecycline, ziconotide, and clofarabine.
Journal of the American Pharmacists Association : JAPhA 20050101
-
Nucleosides as anticancer agents: from concept to the clinic.
Nucleic acids symposium series (2004) 20050101
-
Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome.
Best practice & research. Clinical haematology 20041201
-
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
Journal of clinical pharmacology 20041101
-
Bibliography. Current world literature. Therapeutic modalities.
Current opinion in oncology 20041101
-
Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
Nucleosides, nucleotides & nucleic acids 20041001
-
In vitro assessment of nucleoside analogs in multiple myeloma.
Cancer chemotherapy and pharmacology 20040801
-
Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemia.
Haematologica 20040801
-
Purine nucleoside antimetabolites in development for the treatment of cancer.
Current opinion in investigational drugs (London, England : 2000) 20040601
-
Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.
Blood 20040201
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20040101
-
Clofarabine.
Drugs in R&D 20040101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20040101
-
New nucleoside analogs in the treatment of hematological disorders.
Acta poloniae pharmaceutica 20040101
-
New nucleoside analogs in the treatment of solid tumors.
Acta poloniae pharmaceutica 20040101
-
Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias.
Clinical cancer research : an official journal of the American Association for Cancer Research 20031215
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20031201
-
Clofarabine. Bioenvision/ILEX.
Current opinion in investigational drugs (London, England : 2000) 20031201
-
Induction of complete remission using single agent clofarabine in a patient with primary refractory acute myeloblaste leukemia.
Leukemia & lymphoma 20031201
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20031101
-
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.
Blood 20031001
-
Clofarabine-induced acral erythema during the treatment of patients with myelodysplasia and acute leukemia: report of two cases.
Leukemia & lymphoma 20030801
-
New designs for phase 2 clinical trials.
Blood 20030715
-
Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030315
-
Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia.
Haematologica 20030301
-
Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Biochemical pharmacology 20030115
-
Advanced-phase chronic myeloid leukemia.
Seminars in hematology 20030101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20030101
-
New drugs in acute myeloid leukemia.
Current oncology reports 20020901
-
Mechanisms of the apoptotic activity of Cl-F-araA in a human T-ALL cell line, CCRF-CEM.
Cancer chemotherapy and pharmacology 20020901
-
Hematologic malignancies: new developments and future treatments.
Seminars in oncology 20020801
-
Gateways to Clinical Trials.
Methods and findings in experimental and clinical pharmacology 20020401
-
DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.
Clinical cancer research : an official journal of the American Association for Cancer Research 20011101
-
Nucleoside analogues in the treatment of haematological malignancies.
Expert opinion on pharmacotherapy 20010601
-
Synthesis and biologic activity of 2'-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine.
Journal of medicinal chemistry 19920124
-
Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
Cancer research 19910501